Journal Watch · Science · 2026
A DNA Typewriter records the cell lineage history of a mouse, from zygote to late organogenesis.
A lineage-anchored ontogeny of mammalian development, long out of reach, is coming into view.
TL;DR
A lineage-anchored ontogeny of mammalian development, long out of reach, is coming into view.
Key findings
- Temporal sweeps of clade co-occurrence recover a dated hierarchy of cell-type couplings; imputed labels for internal nodes recapitulate known state paths.
- A lineage-anchored ontogeny of mammalian development, long out of reach, is coming into view.
What they did
A burst of editing unequivocally marks the daughters of the first cleavage, which serve as inline replicates. We quantify clonal dominance arising during gastrulation. Tree siblings share cell type far above chance; heterotypic siblings mark terminal differentiations.
Full abstract (original)
Background: Mammalian biology unfolds over time, within tissues and organs opaque to our eyes and instruments. We applied DNA Typewriter, a sequential molecular recorder, to record the cell lineage of a mouse over nearly two weeks of development. From one embryo, we reconstruct a time-calibrated, parsimony-supported, zygote-rooted phylogeny of 1.28 million transcriptionally profiled cells.
What they did: A burst of editing unequivocally marks the daughters of the first cleavage, which serve as inline replicates. We quantify clonal dominance arising during gastrulation. Tree siblings share cell type far above chance; heterotypic siblings mark terminal differentiations.
Results & conclusions: Temporal sweeps of clade co-occurrence recover a dated hierarchy of cell-type couplings; imputed labels for internal nodes recapitulate known state paths. A lineage-anchored ontogeny of mammalian development, long out of reach, is coming into view.
Abstract © the authors / Science (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/science.ael0508 · PubMed 42848909.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Science for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Science study find?
A lineage-anchored ontogeny of mammalian development, long out of reach, is coming into view.
What type of study is this?
It is a preclinical (animal / model) study, published in Science in 2026. A burst of editing unequivocally marks the daughters of the first cleavage, which serve as inline replicates.
Where can I read the original paper?
The original is at the publisher via DOI 10.1126/science.ael0508. PubMed ID: 42848909. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-dna-typewriter-records-the-cell-lineage-history-of-a-mouse-from-zygote-el0508/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides